Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
04/2007
04/26/2007CA2624166A1 Inhibitors of viral replication
04/26/2007CA2623213A1 Piperazine derivatives as antimalarial agents
04/25/2007EP1777222A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
04/25/2007EP1777221A1 Process for the preparation of 5-cyanophthalide starting from 5-carboxyphthalide
04/25/2007EP1777220A1 Vitamin D derivatives active on the vitamin D nuclear receptor, preparation and uses thereof
04/25/2007EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives
04/25/2007EP1539147A4 Methods of treating microbial infections in humans and animals
04/25/2007EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
04/25/2007CN1953982A 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones
04/25/2007CN1951953A Tanshinone and salvianolic acid B combined production method
04/25/2007CN1951928A Preparation method for tanshinone I
04/25/2007CN1312156C Cembrane form diterpene
04/25/2007CN1312148C Isochroman compounds for treatment of CNS disorders
04/25/2007CN1312145C Process for preparation of 4-phenylacetylene phthalic anhydride
04/25/2007CN1312144C Compound with nematocidal activity and its application
04/25/2007CN1312116C Calcium acceptor active compound
04/25/2007CN1311819C Crystalline composition containing escitalopram
04/24/2007USRE39593 Diastereoisomers with an analgesic effect; suitable for the treatment of severe pain without the side effects of opioids
04/24/2007US7208612 Crystals of LuxP and complexes thereof
04/24/2007US7208497 Substituted piperazines and diazepanes
04/24/2007US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
04/24/2007US7208491 N-monoacylated o-phenylenediamines
04/24/2007US7208482 9-aminoacyl tetracycline compounds and methods of use thereof
04/24/2007US7208450 Pesticidal (dihalopropenyl) phenylalkyl substituted benzoxazole and benzothiazole derivatives
04/24/2007CA2307820C Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007044724A2 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
04/19/2007WO2007043568A1 S1p3 receptor antagonist
04/19/2007WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same
04/19/2007WO2007009389A3 Substituted propanamide derivatives, preparation and use thereof
04/19/2007WO2006131398A3 Inhibitors of soluble adenylate cyclase
04/19/2007US20070088169 Process for the production of ethers
04/19/2007US20070088080 Gsk-3 inhibitors isolated from marine organisms
04/19/2007US20070088067 Novel amidine compounds for treating microbial infections
04/19/2007US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
04/19/2007DE10238257B4 Sorbicillacton A und Sorbicillacton-A-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel Sorbicillactone A and sorbicillactone A derivatives, processes for their preparation and pharmaceutical compositions containing them
04/19/2007CA2626011A1 S1p3 receptor antagonist
04/19/2007CA2623759A1 Pyridopyrimidinone inhibitors of pim 1 and/or pim-3
04/19/2007CA2623327A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
04/18/2007EP1773846A1 Indoleamine 2,3-dioxygenase (ido) inhibitors
04/18/2007EP1773839A1 Synthesis of aldonolactones, aldarolactones, and aldarodilactones using azeotrophic distillation
04/18/2007EP1773838A1 Synthesis of aldonolactones, aldarolactones, and aldarodilactones using gas sparging
04/18/2007EP1773821A2 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders
04/18/2007EP1773799A1 Process for the preparation of optically-active compounds
04/18/2007EP1773780A2 Amido compounds and their use as pharmaceuticals
04/18/2007EP1773746A1 Catalysts for maleic acid hydrogenation to 1,4-butanediol
04/18/2007EP1773398A2 Novel sulfonamides as inhibitors of histone deacetylase for the treatment of disease
04/18/2007EP1453792B1 Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
04/18/2007EP1425276B1 Heterocyclic carboxamides and their use as fungicides
04/18/2007EP1353662B1 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/18/2007EP1052259B1 Novel optically active aminopentane derivative
04/18/2007CN1950425A Method for producing elastomeric copolyesters
04/18/2007CN1950356A Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
04/18/2007CN1950350A Liquid crystal compound comprising two condensed and substituted rings
04/18/2007CN1950334A Ortho substituted aryl or heteroaryl amide compounds
04/18/2007CN1950080A Novel compounds for treatment of cardiac arrhythmia and methods of use
04/18/2007CN1948302A Cesong alkyl type diterpine, its preparation method and use
04/18/2007CN1948301A Process for the preparation of 5-cyanophthalide starting from 5-carboxyphthalide
04/18/2007CN1948300A Phthalidyl derivative and its preparation method, and application as stabilizer
04/18/2007CN1948299A Preparation method of racemic homocitric acid lactone
04/18/2007CN1310887C Method for producing 1,3-disubstituted 2-nitroguanidines
04/18/2007CN1310640C Pharmaceutical compositions
04/17/2007USRE39575 For therapy of sleep, eating and brain disorders, wakefulness promoters; Parkinson's disease, antiischemic agents, stroke, chronic fatigue syndrome; antidepressants; schizophrenia, nervous system disorders; multiple sclerosis, cognition activators
04/17/2007US7205417 Spiro compounds
04/17/2007US7205416 unsubstituted and substituted alpha-methylene lactones by a liquid phase reaction of starting lactones with formaldehyde in the presence of a novel catalyst that exhibits high conversion and selectivity
04/17/2007US7205335 Preparation of cis-fused 3,3a,8,12b-tetrahydro-2H-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan derivatives
04/17/2007US7205333 Therapy for influenza virus; inhaler
04/17/2007US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases
04/17/2007US7205304 medicine to inhibit proliferative conditions, such as cancer and psoriasis
04/17/2007CA2318381C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
04/17/2007CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis
04/12/2007WO2007039915A1 Anti-malarial compound isolated from gomphostema niveum
04/12/2007WO2007039615A1 New n-alkyl-heterocyclyl carboxamide derivatives
04/12/2007WO2007039609A1 Pyranodibenzofuran derivatives with antifungal and antibacterial activity
04/12/2007WO2007039526A1 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof
04/12/2007WO2007039138A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
04/12/2007WO2007039112A1 Novel phloroglucinol derivatives having selectin ligand activity
04/12/2007WO2007008942A3 Phenylamino-acetic acid [1-(pyridin-4-yl)-methylidene]-hydrazide derivatives and related compounds as modulators of g protein-coupled receptor kinases for the treatment of eye diseases
04/12/2007WO2006134163A3 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain
04/12/2007WO2006083417A3 Processes of making sesquiterpenoid tashironin, its analogs and their uses
04/12/2007US20070082897 Acylated indanyl amines and their use as pharmaceuticals
04/12/2007US20070082888 Containing a piperidine ring, e.g., N-(p-(1-(alpha(propyl-aminocarbonyl)benzyl)piperidin-4-yl)phen yl)-o-(p-CF3-phenyl)- benzamide, for therapy of hyperlipidemia, obesity and type II diabetes
04/12/2007US20070082883 HIV protease inhibitors
04/12/2007CA2623731A1 Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof
04/12/2007CA2623725A1 Stable ascorbic acid compositions
04/12/2007CA2623114A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
04/12/2007CA2622467A1 Novel phloroglucinol derivatives having selectin ligand activity
04/11/2007EP1772459A2 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same
04/11/2007EP1772458A2 Novel chromophores for polymeric thin films and optical waveguides and devices comprising the same
04/11/2007EP1772449A1 New N-alkyl-heterocyclyl carboxamide derivatives
04/11/2007EP1771435A2 Modulators of central nervous system neurotransmitters
04/11/2007EP1771432A2 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
04/11/2007EP1771431A1 Intermediates for the preparation of halichondrin b
04/11/2007EP1771232A1 Method for producing dimethylaminoarglabine hydrochloride
04/11/2007EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/11/2007CN1946690A Cyclobutenedione groups-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
04/11/2007CN1946680A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
04/11/2007CN1944427A Novel macro-molecular compound, its preparing method and use
04/11/2007CN1944424A Aryl formyl piperazine compound and its preparing method and use in medicine production